HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aimin Xu Selected Research

CAY 10580

1/2018EP4 emerges as a novel regulator of bile acid synthesis and its activation protects against hypercholesterolemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aimin Xu Research Topics

Disease

97Obesity
01/2022 - 07/2003
92Insulin Resistance
01/2022 - 05/2002
57Type 2 Diabetes Mellitus (MODY)
01/2022 - 12/2004
51Inflammation (Inflammations)
01/2022 - 07/2003
26Hypertension (High Blood Pressure)
01/2022 - 06/2007
24Atherosclerosis
12/2021 - 02/2004
22Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2006
21Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2021 - 07/2003
18Glucose Intolerance
01/2022 - 10/2007
18Hyperglycemia
01/2021 - 05/2002
17Fatty Liver
01/2022 - 07/2003
17Neoplasms (Cancer)
01/2021 - 05/2002
14Non-alcoholic Fatty Liver Disease
01/2022 - 07/2003
11Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021 - 07/2011
11Body Weight (Weight, Body)
01/2018 - 06/2009
10Fibrosis (Cirrhosis)
01/2022 - 06/2005
9Wounds and Injuries (Trauma)
01/2022 - 01/2007
9Carcinogenesis
09/2021 - 12/2006
8Heart Failure
10/2021 - 04/2011
8Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 06/2005
7Dyslipidemias (Dyslipidemia)
01/2022 - 02/2004
7Breast Neoplasms (Breast Cancer)
01/2021 - 12/2006
7Coronary Disease (Coronary Heart Disease)
01/2019 - 08/2005
6Coronary Artery Disease (Coronary Atherosclerosis)
12/2019 - 11/2011
6Hypoadiponectinemia
05/2015 - 02/2004
5Alcoholic Fatty Liver
11/2020 - 02/2013
5Hypercholesterolemia
01/2018 - 02/2004
5Hypoxia (Hypoxemia)
01/2016 - 03/2006
4Mitochondrial Diseases (Mitochondrial Disease)
11/2022 - 10/2008
4Myocardial Infarction
01/2022 - 01/2011
4Atherosclerotic Plaque (Atheroma)
07/2021 - 05/2015
4Metabolic Diseases (Metabolic Disease)
11/2020 - 07/2015
4Prediabetic State (Prediabetes)
01/2020 - 01/2011
4Diabetes Mellitus
12/2019 - 09/2012
4Weight Loss (Weight Reduction)
01/2018 - 07/2003
4Neoplasm Metastasis (Metastasis)
01/2017 - 05/2008
4Liver Diseases (Liver Disease)
01/2016 - 07/2003
4Myocardial Ischemia (Ischemic Heart Diseases)
01/2016 - 01/2011
4Hepatomegaly
12/2010 - 07/2003
3Acute Liver Failure (Fulminant Hepatic Failure)
01/2022 - 09/2014
3Chronic Renal Insufficiency
10/2021 - 02/2017
3Diabetic Retinopathy (Retinopathy, Diabetic)
01/2020 - 02/2017
3Overweight
05/2019 - 05/2008
3Hyperlipidemias (Hyperlipidemia)
01/2019 - 02/2004
3Diabetic Nephropathies (Diabetic Nephropathy)
01/2019 - 01/2009
3Hepatocellular Carcinoma (Hepatoma)
01/2017 - 08/2014
3Reperfusion Injury
01/2016 - 10/2015

Drug/Important Bio-Agent (IBA)

81AdiponectinIBA
01/2021 - 05/2002
60Glucose (Dextrose)FDA LinkGeneric
01/2022 - 12/2004
38Insulin (Novolin)FDA Link
01/2022 - 11/2004
37fibroblast growth factor 21IBA
01/2022 - 05/2008
36AdipokinesIBA
01/2020 - 06/2005
32LipidsIBA
08/2021 - 12/2004
31Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2006
30Fatty Acid-Binding ProteinsIBA
10/2021 - 03/2006
21Lipocalin-2IBA
01/2021 - 01/2007
19Hormones (Hormone)IBA
01/2021 - 05/2002
19Proteins (Proteins, Gene)FDA Link
03/2017 - 12/2004
16CytokinesIBA
01/2021 - 01/2008
14Triglycerides (Triacylglycerol)IBA
01/2022 - 06/2009
13C-Reactive ProteinIBA
01/2022 - 01/2007
13CholesterolIBA
01/2022 - 02/2004
12Pharmaceutical PreparationsIBA
01/2020 - 10/2008
9Sirtuin 1IBA
01/2022 - 08/2012
7Fenofibrate (CiL)FDA LinkGeneric
07/2021 - 12/2012
7Peptides (Polypeptides)IBA
12/2020 - 06/2009
7Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2017 - 01/2010
6Biological ProductsIBA
01/2022 - 02/2007
6Rosiglitazone (Avandia)FDA Link
12/2021 - 01/2007
6Fatty Acids (Saturated Fatty Acids)IBA
01/2019 - 06/2009
5CreatinineIBA
11/2020 - 01/2009
5EnzymesIBA
11/2020 - 10/2007
5Apolipoproteins E (ApoE)IBA
10/2020 - 04/2010
5ApolipoproteinsIBA
10/2020 - 08/2012
5Retinol-Binding Proteins (Retinoid Binding Proteins)IBA
01/2014 - 06/2009
5beta CateninIBA
10/2013 - 12/2006
4Leukocyte Elastase (Neutrophil Elastase)IBA
01/2022 - 12/2014
4CollagenIBA
01/2021 - 06/2005
4Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2020 - 06/2009
4pigment epithelium-derived factorIBA
01/2019 - 11/2010
4AntigensIBA
01/2019 - 01/2017
4AntioxidantsIBA
01/2015 - 03/2006
4Glycoproteins (Glycoprotein)IBA
11/2014 - 07/2006
4Phosphotransferases (Kinase)IBA
01/2012 - 08/2004
3Vitamin DFDA LinkGeneric
01/2022 - 07/2013
3MicroRNAs (MicroRNA)IBA
01/2022 - 01/2012
3InflammasomesIBA
12/2021 - 01/2017
3EndotoxinsIBA
11/2021 - 10/2008
3AutoantibodiesIBA
01/2021 - 01/2019
3Estrogens (Estrogen)FDA Link
01/2021 - 02/2009
3Interleukin-6 (Interleukin 6)IBA
01/2021 - 05/2011
3Toll-Like Receptors (Toll-Like Receptor)IBA
01/2020 - 07/2012
3Vitamin A (Retinol)FDA LinkGeneric
01/2020 - 06/2008
3Plasminogen Activators (Plasminogen Activator)IBA
10/2018 - 03/2006
3AldosteroneIBA
01/2018 - 03/2013
3Streptozocin (Streptozotocin)FDA Link
01/2018 - 10/2013
3Messenger RNA (mRNA)IBA
03/2017 - 03/2006

Therapy/Procedure

12Therapeutics
01/2021 - 02/2004
8Transplantation
01/2020 - 06/2015
4Liver Transplantation
11/2022 - 12/2014